OTCMKTS:SBMFF Sino Biopharmaceutical (SBMFF) Stock Price, News & Analysis $0.70 0.00 (-0.14%) As of 09:34 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and TrendsSEC FilingsShort Interest About Sino Biopharmaceutical Stock (OTCMKTS:SBMFF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sino Biopharmaceutical alerts:Sign Up Key Stats Today's Range$0.70▼$0.7050-Day Range$0.59▼$0.7552-Week Range$0.59▼$1.16Volume1,000 shsAverage Volume3,050 shsMarket Capitalization$13.13 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sino Biopharmaceutical Limited is a China-based pharmaceutical company engaged in the research, development, manufacture and commercialization of medicines. The company offers prescription drugs and other pharmaceutical products across therapeutic areas that include oncology, respiratory diseases, hepatology, cardiovascular conditions, digestive disorders, infectious diseases and orthopedics. Its portfolio includes innovative medicines, specialty therapies and generic drugs. Among its better-known products are anlotinib hydrochloride, an oncology treatment marketed in China, and therapies used in areas such as hepatitis and respiratory disease. Sino Biopharmaceutical also maintains a pipeline of new drug candidates and participates in drug development through its research and development subsidiaries and partnerships. The company has historically operated primarily in mainland China, where its products are marketed through hospitals, pharmacies and other healthcare channels. It has also pursued international registrations, partnerships and market opportunities as part of its broader expansion strategy. Sino Biopharmaceutical is associated with major operating subsidiaries including Chia Tai Tianqing Pharmaceutical Group and Beijing Tide Pharmaceutical, which support its manufacturing, commercial and research activities.AI Generated. May Contain Errors. Read More Receive SBMFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBMFF Stock News HeadlinesSino Biopharm Raises CT Tianqing Stake to 65% in RMB4.48 Billion DealSeptember 11 at 4:51 AM | tipranks.comSino Biopharm’s Kylo-11 Shows Year-Long Lp(a) Cut in Phase I TrialAugust 30, 2026 | tipranks.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 11 at 1:00 AM | Banyan Hill Publishing (Ad)Sino Biopharm Wins China, U.S. Green Lights for Next-Gen Nectin-4 ADC LM-364August 28, 2026 | tipranks.comSino Biopharmaceutical (SBMFF) Receives a Buy from CitiAugust 23, 2026 | theglobeandmail.comSino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International ExpansionAugust 19, 2026 | finance.yahoo.comSino Biopharmaceutical Declares 2026 Interim Dividend of HKD 0.07 Per ShareAugust 19, 2026 | tipranks.comSino Biopharmaceutical Interim Results Highlight Surge in Innovative Drug and Out-Licensing RevenueAugust 19, 2026 | tipranks.comSee More Headlines SBMFF Stock Analysis - Frequently Asked Questions How have SBMFF shares performed this year? Sino Biopharmaceutical's stock was trading at $0.8721 at the beginning of 2026. Since then, SBMFF shares have decreased by 19.7% and is now trading at $0.70. How do I buy shares of Sino Biopharmaceutical? Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/11/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:SBMFF Previous SymbolNASDAQ:SBMFF CIK1604982 Webwww.sinobiopharm.com Phone852-2802-9886Fax852-2880-0847Employees24,379Year Founded1997Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.02 billion Price / Sales3.27 Cash Flow$0.02 per share Price / Cash Flow30.00 Book Value$0.32 per share Price / Book2.19Miscellaneous Outstanding Shares18,760,720,000Free FloatN/AMarket Cap$13.13 billion OptionableNot Optionable Beta0.71 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:SBMFF) was last updated on 9/11/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sino Biopharmaceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share Sino Biopharmaceutical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
